Patents by Inventor David L. Enfield

David L. Enfield has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of screening for or treating cancers or autoimmune disorders in which a complement C3 or C3 related protein is associated
    Publication number: 20010023066
    Abstract: Methods of screening for cancers or treating cancers or autoimmune disorders are disclosed. In an aspect of the present invention, the screening methods are based on the detection of complement C3 or C3 related protein, or a nucleic acid molecule encoding the same, found to be associated with the presence of cancer. Additional screening methods are based on the use of complement regulators Factor I or DAF, or complement receptors 1 or 3. Preferred embodiments to the methods include detection based on immunological properties, physical properties, enzymatic properties and combinations thereof, or detection of a nucleic acid molecule encoding antigen based on nucleic acid amplification.
    Type: Application
    Filed: March 5, 2001
    Publication date: September 20, 2001
    Inventors: Robert J. Kinders, David L. Enfield, G. Michael Hass
  • Methods of screening for colorectal cancers in which a complement Factor I or related protein is associated
    Patent number: 6221621
    Abstract: Methods of screening for cancers or treating cancers or autoimmune disorders are disclosed. In an aspect of the present invention, the screening methods are based on the detection of complement C3 or C3 related protein, or a nucleic acid molecule encoding the same, found to be associated with the presence of cancer. Additional screening methods are based on the use of complement regulators Factor I or DAF, or complement receptors 1 or 3. Preferred embodiments to the methods include detection based on immunological properties, physical properties, enzymatic properties and combinations thereof, or detection of a nucleic acid molecule encoding antigen based on nucleic acid amplification.
    Type: Grant
    Filed: March 5, 1998
    Date of Patent: April 24, 2001
    Assignee: BARD Diagnostic Sciences, Inc.
    Inventors: Robert J. Kinders, David L. Enfield, G. Michael Hass
  • Methods and compositions for screening for or modulating a tumor associated antigen
    Patent number: 6017703
    Abstract: Methods of screening for or treating cancer are disclosed. The screening methods are based on the detection of an antigen, or a nucleic acid molecule encoding the antigen, found by the present invention to be associated with the presence of cancer. Preferred embodiments of the methods include detection of the antigen based on immunological properties, physical properties, enzymatic properties and combinations thereof, or detection of a nucleic acid molecule encoding the antigen based on nucleic acid amplification.
    Type: Grant
    Filed: April 8, 1997
    Date of Patent: January 25, 2000
    Assignee: Bard Diagnostic Sciences, Inc.
    Inventors: Robert J. Kinders, David L. Enfield, G. Michael Hass